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Abstract: Due to their high bioreactivity, the in-vitro analysis of bioactive glasses (BGs) can be
challenging when it comes to maintaining a physiological pH. To improve BG biocompatibility,
a heterogenic spectrum of preconditioning approaches, such as “passivation” of the BGs by incubation
in cell culture medium, are used but have never been directly compared. In this study, the effect of
passivation periods of up to 72 h on pH alkalization and viability of human bone marrow-derived
mesenchymal stromal cells was evaluated to determine a time-efficient passivation protocol using
granules based on the 45S5-BG composition (in wt%: 45.0 SiO2, 24.5 Na2O, 24.5 CaO, 6.0 P2O5) in
different concentrations. pH alkalization was most reduced after passivation of 24 h. Cell viability
continuously improved with increasing passivation time being significantly higher after passivation of
at least 24 h compared to non-passivated 45S5-BG and the necessary passivation time increased with
increasing BG concentrations. In this setting, a passivation period of 24 h presented as an effective
approach to provide a biocompatible cell culture setting. In conclusion, before introduction of BGs
in cell culture, different passivation periods should be evaluated in order to meet the respective
experimental settings, e.g., by following the experimental protocols used in this study.
Keywords: 45S5 bioactive glass; biocompatibility; passivation; cytocompatibility; cytotoxicity; human
bone marrow-derived mesenchymal stromal cells
1. Introduction
Since the introduction of the 45S5-bioactive glass (BG) composition (in wt%: 45.0 SiO2, 24.5 Na2O,
24.5 CaO, 6.0 P2O5) by Hench and coworkers in the late 1960s, the family of BGs grew rapidly [1,2].
Since then, various types of BGs have been investigated in different fields of research including, but not
limited to bone tissue engineering (BTE) [3,4]. For application in BTE, BGs are particularly attractive
due to the changes on their surface when in contact with physiological fluids that lead to strong
bonding to surrounding tissues [5,6]. Furthermore, the release of bioactive ions like silica from the
BGs is known to stimulate osteogenic differentiation of bone precursor cells and the formation and
calcification of the osseous extracellular matrix [7,8].
When new BG compositions are introduced to BTE applications, it is of particular interest
to investigate their biological properties in-vitro, including cytotoxicity assays or their impact on
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osteogenic differentiation [8,9]. As per definition, BGs exhibit a high surface reactivity, allowing their
surface to remodel in contact to fluids due to the following cascade of reactions: Within minutes a rapid
exchange of alkali ions with hydrogen (H+ or H3O+) occurs, leaving a poorly connected silica network
and consecutively leading to the formation of a silica-rich surface layer. Calcium hydroxyl phosphate
precipitates and crystallization leads to the formation of a hydroxycarbonate apatite layer. This layer is
capable of incorporating organic components and allows living bone to bond as it is highly similar to
bone mineral [10–12].
However, the described burst release of alkali ions leads to a strong increase in local pH potentially
resulting in pH-dependent cytotoxicity [13–16]. Apart from a compromise of cell viability, rapid pH
changes in cell culture medium can confound the interpretation of cellular function [17]. Therefore,
when introduced to cell culture studies, BGs have to be prepared using so-called preconditioning
procedures such as “passivation” by introducing the BGs to cell culture medium for a certain period of
time before allowing contact to cells [8,18] to prevent the cells from the initial burst release of ions and
its consequences.
Preconditioning limits the BG-mediated pH changes to a significant extent and does not alter the
hydroxycarbonate apatite (HCA) formation ability as demonstrated by Pryce and co-workers [19].
In a review conducted by our group, different preconditioning approaches were analyzed showing
a broad variety in the used methods [8]. For example, Lin et al. pre-incubated BG-based scaffolds
for 1 h before introduction to a cell culture setting [20] whilst Detsch and co-workers preconditioned
45S5-BG based scaffolds with comparable porosity for 2 weeks before cell seeding [21].
The broad spectrum of passivation protocols might cause confusion when it comes to the planning
of BG-based cell culture studies. Certainly, preconditioning of BGs prior to use in cell culture settings
is important, however, it remains unclear how different passivation periods actually influence cell
viability and growth in one and the same setting.
Therefore, in this study, granules made from 45S5-BG in three different concentrations were
introduced to a culture of human bone marrow-derived mesenchymal stromal cells (BMSCs) without
and with passivation in Dulbecco’s Modified Eagle’s Medium (DMEM) for 1, 6, 24, and 72 h. The impact
of the different preconditioning periods on cell viability and growth patterns as well as their impact on
the pH of the cell culture medium (CCM) was assessed and compared to a control consisting of BMSCs
in BG-free CCM. This work will help researchers to plan cell culture experiments involving BGs more
accurately in a time-effective manner.
2. Materials and Methods
2.1. General Experimental Design: Overview
45S5-BG granules were subjected to dynamic passivation in DMEM high glucose (Life Technologies,
Darmstadt, Germany) for 1 h, 6 h, 24 h, and 72 h respectively. After the designated period of passivation,
pH values of the media utilized for the passivation process were analyzed using pure DMEM as control.
Conditioned medium was discarded and passivated BG granules as well as non-passivated BG granules
(0 h) were added to fresh CCM (89% DMEM high glucose, 10% fetal calf serum (FCS; Life Technologies,
Darmstadt, Germany), 1% penicillin/streptomycin (Biochrom, Berlin, Germany)). Medium containing
the BG granules was placed in 96-well cell culture plates (Nunc, Roskilde, Denmark) and BMSCs
were added achieving a cell density of 2 × 104 cells per cm2 and final BG concentrations of 1, 2.5,
and 5 mg/mL. A control group was composed of BMSCs in BG-free CCM while each group consisted
of 5 biological replicates. After 1 (D1) and 3 (D3) days of incubation the middle concentration of
2.5 mg/mL was used to evaluate pH values in the CCM and microscopically analyze cell morphology
and growth patterns in direct presence of the differently preconditioned BGs. To quantify the influence
on cell viability a fluorescence-based assay was performed for all groups as schematically depicted in
Figure 1.
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Figure 1. Schematic overview of the experimental design. Bioactive glass (BG) granules were 
passivated for 1, 6, 24, and 72 h respectively. pH values of the Dulbecco's Modified Eagle's Medium 
(DMEM) used for passivation were measured. Passivated BGs and non-passivated BGs (0 h) at 
different concentrations were co-cultured with human bone marrow-derived mesenchymal stromal 
cells (BMSCs) while cells in BG-free cell culture medium (CCM) served as control. On day 1 (D1) and 
day 3 (D3) the average BG concentration was used for pH evaluation and microscopical analysis of 
cell growth patterns, whereas a quantification of cell viability in all groups was performed at BG 
concentrations of 1, 2.5, and 5 mg/ml. 
2.2. BG Production and Characterization 
45S5-BG was prepared following the melt-quench route using analytical grade reagents, namely, 
NaCO3 (Honeywell Fluka, Steinheim, Germany), CaCO3 (Honeywell Fluka, Steinheim, Germany), 
CaHPO4·2H2O (Acros Organics, Geel, Belgium), and commercial grade Belgian quartz sand (SiO2). The 
reagents were mixed together in a platinum crucible, heated up to 1400 °C for 1 h and quenched rapidly 
in water. The glass frits were crushed with a Jaw Crusher (Retsch, Haan, Germany) and ground into 
fine powder with a planetary ball mill (Retsch, Haan, Germany) with absolute ethanol (VWR 
Chemicals, Radnor, PA, USA) as milling medium. The powder was subsequently sintered at 1050 °C 
for 2 h, ground and sieved to obtain particles less than 125 µm. The morphology of the final granules 
was characterized by a polygonal shape with average size of 66 ± 19 µm as depicted in Figure 2 (SEM 
Auriga, Carl-Zeiss, Jena, Germany). The average size was estimated from scanning electron microscopy 
(SEM) images using the software ImageJ (National Institutes of Health Bethesda, MD, USA). 
 
Figure 1. Schematic overview of the experimental design. Bioactive glass (BG) granules were passivated
for 1, 6, 24, and 72 h respectively. pH values of the Dulbecco’s Modified Eagle’s Medium (DMEM) used
for passivation were measured. Passivated BGs and non-passivated BGs (0 h) at different concentrations
were co-cultured with human bone marrow-derived mesenchymal stromal cells (BMSCs) while cells in
BG-free cell culture medium (CCM) served as control. On day 1 (D1) and day 3 (D3) the average BG
concentration was used for pH evaluation and microscopical analysis of cell growth patterns, whereas
a quantification of cell viability in all groups was performed at BG concentrations of 1, 2.5, and 5 mg/mL.
2.2. BG Production and Characterization
45S5-BG was prepared following the melt-quench route using analytical grade reagents, namely,
NaCO3 (Honeywell Fluka, Steinheim, Germany), CaCO3 (Honeywell Fluka, Steinheim, Germany),
CaHPO4·2H2O (Acros Organics, Geel, Belgium), and commercial grade Belgian quartz sand (SiO2).
The reagents were mixed together in a platinum crucible, heated up to 1400 ◦C for 1 h and quenched
rapidly in water. The glass frits were crushed with a Jaw Crusher (Retsch, Haan, Germany) and ground
into fine powder with a planetary ball mill (Retsch, Haan, Germany) with absolute ethanol (VWR
Chemicals, Radnor, PA, USA) as milling medium. The powder was subsequently sintered at 1050 ◦C
for 2 h, ground and sieved to obtain particles less than 125 µm. The morphology of the final granules
was characterized by a polygonal shape with average size of 66 ± 19 µm as depicted in Figure 2 (SEM
Auriga, Carl-Zeiss, Jena, Germany). The average size was estimated fro scanning electron microscopy
(SEM) images using the softw re ImageJ (N tional Institutes of Health Bethesda, MD, USA).
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Figure 2. Scanning electron microscopy (SEM) image of the investigated bioactive glass (BG) granules 
prior to passivation depicted at a 200-fold magnification. The image was taken using a secondary 
electron detector, at a voltage of 1.5 kV and working distance of 5.1 mm. The reference bar refers to 
400 µm. 
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sterilized at 160 °C for 30 min. During the sterilization period, the 45S5-BG granules were stored in a 
glass beaker that was airtight sealed with aluminum foil. The sterilized BG granules were then added 
to DMEM high glucose at a concentration of 5 mg/ml and transferred to 50 ml falcon tubes (Merck, 
Darmstadt, Germany). On an orbital shaker (neoLab, Heidelberg, Germany) the BG was incubated at 
37 °C and 5% CO2 at 100 rpm. After 1, 6, 24, and 72 h the falcon tubes were centrifuged at 10,000 rpm 
for 10 min; supernatant was removed and used for pH evaluation. BG-granules were kept dry until 
added to CCM at concentrations of 1, 2.5, and 5 mg/ml.  
2.4. Study Ethics and Cell Origin 
BMSCs of a 20-year-old male patient undergoing surgery at the proximal femur at the 
Heidelberg University Hospital were harvested. Prior to cell collection, written consent was obtained 
from the patient and the responsible ethics committee of the Medical Faculty of Heidelberg 
University approved the study (S-340/2018). 
2.5. BMSC Isolation, Cultivation, and Characterization 
BMSCs were isolated from bone marrow washouts as described previously [22–24]. In short, bone 
marrow was collected in a heparinized syringe and cells were fractioned on a Ficoll-Paque Plus density 
gradient (GE Healthcare Europe, Freiburg, Germany). The fraction of mononuclear cells containing the 
BMSCs was washed in PBS (Life Technologies, Darmstadt, Germany) and seeded in several 0.1% 
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(Abcam, Cambridge, U.K.). To discard non-adherent cells, medium was changed after the first 24 h 
and subsequently twice weekly. Cells were passaged at 80% confluency and stored in liquid nitrogen 
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2.3. Passivation of the BG-Particles
In a heating and drying oven (Heraeus Instruments, Hanau, Germany) 45S5-BG granules were
sterilized at 160 ◦C for 30 min. During the sterilization period, the 45S5-BG granules were stored in
a glass beaker that was airtight sealed with aluminum foil. The sterilized BG granules were then added
to DMEM high glucose at a concentration of 5 mg/mL and transferred to 50 mL falcon tubes (Merck,
Darmstadt, Germany). On an orbital shaker (neoLab, Heidelberg, Germany) the BG was incubated at
37 ◦C and 5% CO2 at 100 rpm. After 1, 6, 24, and 72 h the falcon tubes were centrifuged at 10,000 rpm
for 10 min; supernatant was removed and used for pH evaluation. BG-granules were kept dry until
added to CCM at concentrations of 1, 2.5, and 5 mg/mL.
2.4. Study Ethics and Cell Origin
BMSCs of a 20-year-old male patient undergoing surgery at the proximal femur at the Heidelberg
University Hospital were harvested. Prior to cell collection, written consent was obtained from the
patient and the responsible ethics committee of the Medical Faculty of Heidelberg University approved
the study (S-340/2018).
2.5. BMSC Isolation, Cultivation, and Characterization
BMSCs were isolated from bone marrow washouts as described previously [22–24]. In short, bone
marrow was collected in a heparinized syringe and cells were fractioned on a Ficoll-Paque Plus density
gradient (GE Healthcare Europe, Freiburg, Germany). The fraction of mononuclear cells containing
the BMSCs was washed in PBS (Life Technologies, Darmstadt, Germany) and seeded in several 0.1%
gelatin-coated (Sigma-Aldrich, Steinheim, Germany) T75 cell culture flasks (Nunc, Roskilde, Denmark).
Cells were cultivated in expansion medium composed of DMEM high glucose supplemented
with 12.5% FCS, 1% penicillin/streptomycin, 1% L-glutamine (Life Technologies, Darmstadt,
Germany), 1% non-essential amino acids (NEAA; Life Technologies, Darmstadt, Germany),
0.1% β-mercaptoethanol (Life Technologies, Darmstadt, Germany) and 4 ng/mL fibroblast growth
factor 2 (Abcam, Cambridge, U.K.). To discard non-adherent cells, medium was changed after the
first 24 h and subsequently twice weekly. Cells were passaged at 80% confluency and stored in liquid
nitrogen until further use in passage 4.
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2.6. Evaluation of pH
Prior to the start of the incubation, pH values of the medium used for preconditioning of the BG
were measured. The conditioned medium, as well as pure DMEM serving as control, were transferred
to falcon tubes, which were left open in an incubator for 5 min at 37 ◦C and 5% CO2 to level CO2
contents. Then pH was measured using a benchtop pH meter (Sartorius, Göttingen, Germany).
In order to evaluate the development of the pH during incubation, cells were cultivated in
CCM, one group containing non-conditioned BG granules (0 h), four groups containing the BG being
passivated for the designated amounts of time and a control group consisting of BMSCs in BG-free
CCM. Supernatant of all groups was collected after 1 and 3 days and subjected to pH measurement as
described above.
2.7. Visual Assessment of Cell Morphology and Growth Patterns
For the visual evaluation of cell morphology and growth patterns, BMSCs were stained with
fluorescein diacetate (FDA). FDA can freely pass the cell membrane, then being intracellularly
hydrolyzed to the green-fluorescent fluorescein by viable cells [24,25]. To achieve a better
depiction of the BG granules and simultaneously visualize potentially remaining dead cells,
propidium iodide (PI), which is not membrane-permeable and thus selectively intercalating into
DNA of membrane-compromised cells [24,25], was used. After removal of supernatant 200 µL
of staining solution including 8 µg/mL FDA (Sigma-Aldrich, Steinheim, Germany) and 20 µg/mL
PI (Life Technologies, Darmstadt, Germany) were added to each well and incubated at 37 ◦C for
5 min. After being washed and kept in PBS, viability was analyzed using an Olympus IX-81 inverted
fluorescence microscope (Olympus, Hamburg, Germany).
2.8. Quantification of Cell Viability
For quantitative assessment of cell viability three different BG concentrations, being 1, 2.5,
and 5 mg/mL, were used to evaluate whether BG passivation has influence in a dose-dependent manner.
After removing CCM and washing cells in 100 µL PBS, 10 µg/mL FDA staining solution was
added to the BMSCs. Culture plates were incubated for 5 min at 37 ◦C. Cells were washed in 100 µL
PBS and thereafter lysed in 150 µL 0.5% Triton X-100 (Sigma-Aldrich) for 5 min. In a Wallac 1420 Victor
microplate reader (Perkin Elmer, Waltham, MA, USA) fluorescence was detected at 535 nm.
2.9. Statistics
All groups consisted of five biological replicates. IBM SPSS Statistics (Version 25; IBM, Armonk,
NY, USA) was used for statistical analysis. Passivated BG-groups were tested versus non-passivated
BG and the control group using a paired t-test accepting p < 0.05 as the level of significance. Graphical
design was performed with GraphPad Prism (Version 8.1.0; GraphPad Software, La Jolla, CA, USA).
All values are shown as rounded means with standard deviation where applicable.
3. Results
3.1. The Impact of Passivation Periods on BG-Induced pH Alkalization of Cell Medium
The pH values measured in the media used for the passivation of 1 to 72 h were significantly
higher than in the DMEM serving as control, that has not been in contact with BG (Figure 3a). At both
time points in the cell culture setting, the highest pH values occurred in the group with non-passivated
BG and decreased continuously with increasing duration of preconditioning except the 72 h-passivated
group which was showing a minor increase (Figure 3b).
On D3, all BG groups showed significantly higher pH values than the control. On both days, the
24 h passivated group showed the same pH as the pure medium (control group) on D1 (Figure 3b).
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as means with standard deviation. Significant differences to the control group are indicated by (#), 
while (+) shows significant deviation to the non-passivated BG group. 
3.2. Impact on Cell Morphology and Growth Patterns Particularly Showed during Early Incubation Period 
The effect of BG passivation had the most visible impact on D1 as could be observed in the 
microscopical analysis (Figure 3). While the physical presence of non-passivated 45S5-BG had the 
most negative influence on the consistent growth of BMSCs, cell density improved with increasing 
duration of preconditioning, being comparable to the control in the 72 h group. In the non-passivated 
BG group, cell density remained comparably low until D3, while cells cultivated with passivated BG 
grew faster. On D3, BMSCs in the passivated BG groups showed an increased adherence to the BG 
granules forming cell agglomerates. Nevertheless, BG presence led to lower cell density compared to 
the BG-free control (Figure 4). 
Due to the performed washing steps detached dead cells could not be observed. However, PI 
staining led to an orange appearance of the BG granules (Figure 4).  
Figure 4. FDA/PI-staining presenting viable cells green-fluorescent and DNA of dead cells  
red-fluorescent. BG granules appear in orange color. Magnification: 40-fold, reference bar refers to  
800 µm. 
3.3. Passivation Mediated Reduction of BG-Induced Cytotoxicity on All Days 
The quantitative evaluation of cell viability showed different impacts of BG passivation depending 
on the used BG concentration (Figure 5). The viability of cells exposed to BG granules at a concentration 
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while (+) shows significant deviation to the non-passivated BG group.
3.2. Impact on Cell Morphol gy and Growth Patterns Particularly Showed during Early Incubation eri
The ffect of BG passivation had the most visible impact on D1 as could be obser i
microscopical analysi (Figure 3). While the physical presence of non-passivate 4
most negative influence on the consi tent growth of BMSCs, cel density improve it i cr
duration of preconditioni g, being comparable to the control in the 72 h group. I t
BG group, cell density remained comparably low until D3, while cells cultivated it i
grew faster. On D3, BMSCs in the passivated BG groups showed an increased a r t t
granules forming cell ag lomerates. Nevertheless, BG presence led to lo er cell e sit c re t
the BG-free control (Figure 4).
Due to the performed washing steps detached dead cells could not be observed. o ever, PI
staining led to an orange appearance of the BG granules (Figure 4).
Methods and Protoc. 2020, 3, 38 6 of 13 
 
On D3, all BG groups showed significantly higher pH values than the control. On both days, the 
24 h passivated group showed the same pH as the pure medium (control group) on D1 (Figure 3b). 
Figure 3. Evaluation of pH values. (a) pH values of the media used for preconditioning of the BG after 
1, 6, 24, and 72 h in comparison to pure DMEM serving as control. Due to the missing passivation 
period, no pH values were obtained for the 0 h group since the BGs were directly introduced to the 
CCM without passivation. (b) pH values of all groups after 1 and 3 days in CCM. Values are displayed 
as means with standard deviation. Significant differences to the control group are indicated by (#), 
while (+) shows significant deviation to the non-passivated BG group. 
3.2. Impact on Cell Morphology and Growth Patterns Particularly Showed during Early Incubation Period 
The effect of BG passivation had the most visible impact on D1 as could be observed in the 
microscopical analysis (Figure 3). While the physical presence of non-passivated 45S5-BG had the 
most negative influence on the consistent growth of BMSCs, cell density improved with increasing 
duration of preconditioning, being comparable to the control in the 72 h group. In the non-passivated 
BG group, cell density remained comparably low until D3, while cells cultivated with passivated BG 
grew faster. On D3, BMSCs in the passivated BG groups showed an increased adherence to the BG 
granules forming cell agglomerates. Nevertheless, BG presence led to lower cell density compared to 
the BG-free control (Figure 4). 
Due to the performed washing steps detached dead cells could not be observed. However, PI 
staining led to an orange appearance of the BG granules (Figure 4).  
Figure 4. FDA/PI-staining presenting viable cells green-fluorescent and DNA of dead cells  
red-fluorescent. BG granules appear in orange color. Magnification: 40-fold, reference bar refers to  
800 µm. 
3.3. Passivation Mediated Reduction of BG-Induced Cytotoxicity on All Days 
The quantitative evaluation of cell viability showed different impacts of BG passivation depending 
on the used BG concentration (Figure 5). The viability of cells exposed to BG granules at a concentration 
Figure 4. FDA/PI-staining presenting viable cells green-fluorescent nd DNA f ead cells red-fluorescent.
BG granules appear in orange color. Magnification: 40-fold, reference bar refers to 800 µm.
3.3. Passivation Mediated Reduction of BG-Induced Cytotoxicity on All Days
The quantitative evaluation of cell viability showed different impacts of BG passivation depending
on the used BG concentration (Figure 5). The viability of cells exposed to BG granules at a concentration
of 5 mg/mL was significantly compromised at all times during the incubation period. Only BG
passivation for 72 h caused a significant enhancement of viability compared to the non-passivated BG.
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On both days at a concentration of 2.5 mg/mL, a preconditioning period of at least 24 h significantly
improved viability compared to the non-passivated 45S5-BG group and cell viability was continuously
improving with the duration of preconditioning (Figure 5).
At a concentration of 1 mg/mL no relevant advantages of BG passivation were found on D1, most
likely due to a concentration-dependent lower overall cytotoxicity. On D3, an increasing viability was
observed for longer preconditioning periods, showing significantly higher viability in all passivated
BG groups compared to non-passivated BG (Figure 5).
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4. Discussion
BGs increasingly gained in importance in the field of tissue engineering due to their many favorable
properties, such as their proven ability to bond to hard and soft tissue [2,9,11,26]. When introduced to
a static cell culture setting the high bioreactivity of BGs becomes a challenge due to the possible cytotoxic
impact on cells [8]. While the dynamic conditions of an in-vivo setting permit the continuous dilution
of ionic dissolution products, ions accumulate in a static cell culture setting leading to an excessive pH
increase [27] that can be minimized through preconditioning approaches, e.g., by passivation of the BG
prior to introduction to cell culture. Preconditioning of BG scaffolds has also been shown to enhance
the scaffold in-vivo capacity of bone regeneration [28]. Nevertheless, this study focused on the aspects
relevant for in-vitro settings necessary before progression to an animal model.
The analysis of the applied preconditioning procedures used over the last decades on the one hand
demonstrated that the bioco patibility of BGs can be i proved through passivation and on the other
hand revealed the broad variety of utilized ethods [8]. The available studies used individual settings
concerning the choice of edia and ti e used for the passivation, different shapes and compositions
of BGs and the cell type exposed to the material, thus making it difficult to compare the efficiency of
the used procedures. The range of the time periods sche uled for the passivation w s broad, varying
from 1 h to 24 days [8]. Therefore, to d termine the most time- and cost-efficient a proach, being as
uncomplicated as pos ible hile still i i i l ll lt re setting, a direct comparison
was inevitable.
In this study D E as c s , it is one of the most commonly
used cell culture media [29]. t ics ay vary depending on the
utilized medium [30], D E ro i s i i ti ility as solvents without
organic components or si l t fl rs t e a a propriate choice for
BG-pas ivation. The BG examined is the 45S5-BG composition, not only because it is well- haracterized
and often us d but lso because of its known cytotoxic effects in cell culture settings based on the
high sodium content [13,16]. The cells used in this setting are huma BMSCs, which exhibit favorable
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qualities for in-vitro and in-vivo BTE projects [9]. The periods of time determined for passivation are
oriented towards the recommendations resulting from the literature, choosing 72 h as the maximum [8].
In this study all periods of passivation led to a reduction of pH-alkalization in the CCM and
the BG induced cytotoxicity. The maximum pH observed in the non-passivated BG group almost
reached a value of 8.4 clearly surpassing the physiological range. Longer passivation periods sustained
more physiological pH values leveling the initial pH of 8, measured in the control group on D1,
after a passivation period of 24 h. Regarding the absolute pH values it should be mentioned that the
pH value of pure DMEM being 8 on D1 is relatively high. A slight elevation might be explained by the
fact that cell culture occurred at the conventional 5% CO2 while DMEM is buffered to pH 7.4 at 10%
CO2. Moreover, a benchtop pH-meter was used for pH evaluation at ambient air, shortly exposing the
samples to comparably lower CO2 levels.
Between D1 and D3, the pH in the control group decreased—most likely due to acidic products
of glycolytic cell metabolism [31]. Simultaneously, in the BG groups passivated for less than 24 h,
the influence of metabolism was hidden by the alkalizing effect of the BG. Therefore, in the shortly
passivated BG groups pH was further increasing between D1 and D3 while a passivation of at least
24 h could prevent a progression of pH-alkalization.
Cell viability was evaluated using an FDA-based fluorescence assay which was recently shown to
directly correlate with cell number [32]. Therefore, absolute fluorescence intensities serve as direct
correlates for both cell viability and number of viable cells. Alongside the changes in pH values,
quantification of cell viability showed a positive tendency towards longer passivation periods at all
concentrations. At the highest BG concentration, the cytotoxic impact of the BG was most pronounced
only showing significantly higher cell viability in the 72 h passivated group. The lowest concentration,
on the other hand, showed significantly higher viability for all passivated BGs compared to the
non-passivated BG on D3, demonstrating that the passivation period needs to be adapted to the utilized
BG concentration.
In this setting, a BG-concentration of 2.5 mg/mL was most suitable to evaluate the effects of BG
preconditioning and is thus basis for the further discussion of the results. Here the BGs passivated
for 24 h and 72 h showed significantly improved biocompatibility compared to the non-passivated
BG on both days with the BGs passivated for 72 h showing the best properties in quantitative and
qualitative analysis of cell viability. This might indicate that reducing pH to values around 8 is
sufficient to provide a supporting environment for osteoblast precursor cells. Findings in literature
are recommending different pH ranges as an optimum to improve cell proliferation and osteogenic
differentiation. While Galow et al. demonstrated an enhanced proliferation and activity of osteoblasts
at an alkalized pH in the range of 8.0–8.4 in-vitro [33], Monfoulet et al. stated an inhibition of osteogenic
differentiation of BMSCs at pH values higher than 7.9 [34]. However, in our study BG-induced pH
values below 8.1 were tolerated by BMSCs whereas more excessive alkalization led to increasing
compromise of viability.
In the quantitative evaluation as well as the fluorescence microscopy, cell viability visibly increased
in the control group between D1 and D3 as expected for the used culture setting [35,36]. In the meantime,
for all BG groups viability remained at a similar level up to D3. Similar early cytostatic effects of
BG extracts, attributed to a pronounced initial Ca2+ elution, were observed by Alcaide et al. [37].
This could mean, that despite passivation, cell viability is still impacted by the initial ion release of the
BG, thus delaying the expected peak in cell proliferation due to a preceding stage of regeneration.
Furthermore, in the fluorescence microscopy it could be observed, that on D3 cells grew in
agglomerates around passivated BG granules, especially in the 6 h and 24 h group. Preconditioning has
been shown not to limit the HCA forming abilities of BGs [19]. In fact, the thickness of the HCA layer
is seen to increase with longer period of contact with the medium [30,38,39]. It takes approximately
3 days for 45S5-BG to develop a HCA layer in DMEM [38]. On D3 of the culturing period different
extents of HCA development can be expected, thus explaining a higher affinity of MSCs towards
longer passivated granules.
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A passivation period of more than 24 h did not show explicit advantages as passivation of the BGs
for 24 h could prevent a strong pH alkalization. Nevertheless, cell viability was higher when BGs were
passivated for 72 h despite the slightly higher pH. This advantage cannot be stated to pH alterations
only but might be caused by the dynamic of pH alkalization that is disregarded when interpreting
singular pH values. Especially the fast succession of pH alkalization may compromise cell metabolism
and can cause enzyme alterations by influencing cell respiration [8,40]. Hence, passivation for 72 h is
possibly providing a more stable milieu and better preventing rapid pH fluctuations. It should also be
mentioned that ion release kinetics in the periphery and the inner region of BGs differ [41], thus making
the measured pH values in the medium only a very indirect way to estimate the microenvironmental
milieu at the BG/cell interface.
In this particular setting a passivation period of 24 h was sufficient to improve BG-biocompatibility.
Nevertheless, the comparison of different BG concentrations showed that the required extent of
passivation strongly depends on the used BG concentration [9,42]. Thus, the individuality of every
setting makes a reassessment of adequate passivation periods inevitable. Further aspects impacting
the primary biocompatibility of a setting are the BG-morphology (e.g., particle size and surface area)
and -composition that are leading to altered ion release kinetics [16,18,19,37,43,44]. In this study, the
concentration of ions released to the CCM has not been determined, as the dissolution characteristics of
the 45S5-BG are well known [16,19,45–47]. An attractive possibility to evaluate the specific influence of
ionic dissolution products is a setting including ICP-OES analysis and an indirect culturing approach,
where cells are exposed to dissolution products instead of direct contact to the BG [15,16,48]. Especially
when working with less well characterized BGs the suggested setting might further increase the
understanding of BG-related cytotoxic effects.
When working with BGs demanding more extended passivation periods, renewing the medium
during passivation might also be considered to better simulate physiological conditions [49]. As the
main objective of this study was to distinguish a protocol that maximizes time-efficiency and involves
the fewest possible work steps, we decided not to change the medium during the passivation periods.
It is also known that biomaterial-containing cell culture settings have a dissimilar impact on
different cell types. A comparison of frequently used cell types in co-culture with 45S5-BG previously
revealed that several osteoblast-like cell lines show high sensitivity to BG-induced cytotoxicity while
other cells, namely primary human osteoblasts, BMSCs and the osteoblast-like cell line MG-63,
presented as a suitable choice for BTE projects due to a higher tolerance towards cytotoxic effects [9].
According to these findings, there is no general solution for every particular setting. However, BG
preconditioning by dynamic passivation in DMEM for 24 h following the protocol used in this study can
be used as a guideline for planning a new experimental setting and can be adapted under consideration
of the above-mentioned aspects.
5. Conclusions
The aim of this study was to compare BG passivation protocols and to find a suitable protocol
for the use in static cell culture settings, that would minimize BG-provoked cytotoxicity and at the
same time maximize time efficiency. The comparison of 4 different passivation periods of up to 72 h
showed that the BG induced pH alkalization, that is held at least in parts responsible for cytotoxic
effects on cells, was best reduced by a passivation of 24 h. Cell viability was continuously higher
with longer periods of passivation revealing only a slight advantage for the 72 h passivated BGs
over the BGs with 24 h of passivation. In accordance with these findings it can be assumed that BG
passivation for 24 h for granules morphologically comparable to those used in this study is sufficient
for static cell culture experiments. Our study also shows that dynamic passivation is an effective way
to increase the compatibility of BGs for cell culture settings. Before introduction of BGs in cell culture,
different passivation periods should be evaluated in order to meet the respective experimental settings
(BG composition, BG morphology, cell types, etc.), e.g., by following the experimental protocols used
in this study.
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Abbreviations
BG bioactive glass
BMSC bone marrow-derived stromal cell
BTE bone tissue engineering
CCM cell culture medium
CO2 carbon dioxide
DMEM Dulbecco’s Modified Eagle’s Medium
FDA fluorescein diacetate
HCA hydroxycarbonate apatite
NEAA non-essential amino acids
PBS phosphate buffered saline
PI propidium iodide
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